Bale, A.E., Nebert, D.W., and McBride, O.W. (1987). "Subchromosomal localization of the dioxin-inducible P,450 locus (CYP1) and description of two RFLPs detected with a 3' P 1450 cDNA probe."Cytogenet. Cell. Genet.46:574-575.
2.
Brown, A.W.A. (1960). "Mechanisms against resistance against insecticides."Annu. Rev. Entomol.5:301-29.
3.
Butler, M.A., Lang, N.P., Young, J.F., Caporaso, N.E., Vineis, P., Hayes, R.B., et al. (1992). "Determination of CYP1A2 and acetyltransferase phenotype in human populations by analysis of caffeine urinary metabolites."Pharmacogenetics2:116-127.
4.
Cairns, J.C., Overbaugh, J., and Miller, S. (1988). "The origin of mutants."Nature335:142-145.
5.
Caporaso, N., Landi, M.T., and Vineis, P. (1991). "Relevance of metabolic polymorphisms to human carcinogenesis: evaluation of epidemiologic evidence."Pharmacogenetics1:4-19.
6.
Chang, C.Y., Smith, D.R., Prasad, V.S., Sidman, C.L., Nebert, D.W., and Puga, A. (1993). "Ten nucleotide differences, five of which cause amino acid changes, are responsible for the Ah receptor locus polymorphism of C57BL/6 and DBA/2 mice."Pharmacogenetics3:312-321.
7.
Chapela, I.H., Rehner, S.A., Schultz, T.R., and Mueller, U.G. (1994). "Evolutionary history of the symbiosis between fungus-growing ants and their fungi."Science266:1691-1694.
8.
Daly, A.K., Cholerton, S., Armstrong, M., and Idle, J.R. (1994). "Genotyping for polymorphisms in xenobiotic metabolism as a predictor of disease susceptibility."Environ. Health Perspect.102, Suppl. 9:55-61.
9.
Dover, G.A. (1986). "Molecular drive in multigene families: How biological novelties arise, spread and are assimilated."Trends Genet.2:159-165.
10.
Dziuk, L.J. and Plapp, F.W., JR. (1973). "Insecticide resistance in mosquitofish from Texas."Bull. Environ. Contam. Toxicol.9:5-19.
11.
Endler, J.A."Variations in the appearance of guppy color patterns to guppies and their predators under different visual conditions."Visual Res.31:587-608.
12.
Eshleman, A.J. and Murray, T.F. (1991). "Pyrethroid insecticides indirectly inhibit GABA-dependent 36Cl- influx in synaptoneurosomes from the trout brain."Neuropharmacol.30:1333-1341.
13.
Fernandez-Salguero, P., Pineau, T., Hilbert, D.M., McPhail, T., Lee, S.S.T., Kimura, S., Nebert, D.W., Rudikoff, S., Ward, J.M., and Gonzalez, F.J. (1995). "Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor."Science268:722-726.
14.
Ffrench-Constant, R.H. (1993). "Cloning of the Drosophila cyclodiene insecticide resistance gene: a novel GABAA receptor subtype?"Comp. Biochem. Physiol.104C:9-12.
15.
Ffrench-Constant, R.H., Steichen, J.C., Rocheleau, T.A., Aronstein, K., and Roush, R.T. (1993). "A single-amino acid substitution in a -aminobutyric acid subtype A receptor locus is associated with cyclodiene insecticide resistance in Drosophila populations."Proc. Natl. Acad. Sci. USA90:1957-1961.
16.
Fujii-Kuriyama, Y., Ema, M., Matsushita, N., and Sogawa, K. (1995). "Polymorphic forms of the Ah receptor and induction of the CYP1A1 gene."Pharmacogenetics5:S149-S153.
17.
Goedde, H.W. and Agarwal, D.P. (1986). "Aldehyde oxidation: ethnic variations in metabolism and response." In: Ethnic Differences in Reactions to Drugs and Xenobiotics. (W. Kalow, H.W. Goedde, D.P. Agarwal, eds.) Alan R. Liss, New York, NY. pp. 113-138.
18.
Gonzalez, F.J. and Idle, J.R. (1994). "Pharmacogenetic phenotyping and genotyping: Present status and future potential."Clin. Pharmacokinet26:59-70.
19.
Gonzalez, F.J. and Nebert, D.W. (1990). "Evolution of the P450 gene superfamily: Animal-plant 'warfare,' molecular drive, and human genetic differences in drug oxidation."Trends Genet.6:182-186.
20.
Hankinson, O. (1995). "The aryl hydrocarbon receptor complex."Annu. Rev. Pharmacol. Toxicol.35:307-340.
21.
Hayashi, S., Watanabe, J., and Kawajiri, K. (1992). "High susceptibility to lung cancer analyzed in terms of combined genotypes of P450IA1 and mu-class glutathione S-transferase genes."Jpn. J. Cancer Res.83:866-870.
22.
Higuchi, S., Parrish, K.M., Dufour, M.C., Towle, L.H., and Harford, T.C. (1992). "The relationship between three subtypes of the flushing response and DSM-III alcohol abuse in Japanese."J. Stud. Alcohol. 53:553-560.
23.
Humbert, R., Adler, D.A., Disteche, C.M., Hassett, C., Omiecinski, C.J., and Furlong, C.E. (1993). "The molecular basis of the human serum paraoxonase activity polymorphism."Nature Genet.3:73-76.
Kalow, W. (1992). "Pharmacoanthropology and the genetics of drug metabolism." In: Pharmacogenetics of Drug Metabolism. (W. Kalow, ed.) Pergamon Press, New York, NY. pp. 865-877.
26.
Kalow, W., and Bertilsson, L. (1994). "Interethnic factors affecting drug response."Advanc. Drug Res.25:1-53.
27.
Kingman, S. (1995). "Does a CF gene confer a hidden advantage?"J. N.I.H. Res.7:34-35.
28.
Kouri, R.E., McKinney, C.E., Slomiany, D.J., Snodgrass, D.R., Wray, N.P., and McLemore, T.L. (1982). Positive correlation between high aryl hydrocarbon hydroxylase activity and primary lung cancer as analyzed in cryopreserved lymphocytesCancer Res.42:5030-5037.
29.
Krynetski, E., Tai, H.L., Yates, C.R., Fessing, M., Loennechen, T., Schuetz, J.D., et al."Genetic polymorphism of thiopurine s-methyltransferase: clinical importance and molecular mechanisms."Pharmacogenetics6. (In press)
30.
Lander, E. and Schork, N.J. (1994). "Genetic dissection of complex traits."Science265:2037-2048.
31.
Lewalter, J. and Korallus, U. (1985). "Blood protein conjugates and acetylation of aromatic amines."Int. Arch. Occup. Environ. Health.56:179-196.
32.
Liang, H.C., Li, H., Mckinnon, R.A., Duffy, J.J., Potter, S.S., et al. (1996). "CYP1A2(-/-) null mutant mice develop normally, but show altered drug metabolism."Proc. Natl. Acad. Sci. USA93:1671-1676.
33.
Nebert, D.W. (1979). "Multiple forms of inducible drug-metabolizing enzymes. A reasonable mechanism by which any organism can cope with adversity."Mol. Cell. Biochem.27:27-46.
34.
Nebert, D.W. ( 1989). "The AH locus: genetic differences in toxicity, cancer, mutation, and birth defects."Crit. Rev. Toxicol.20:153-174.
35.
Nebert, D.W. (1991). "Role of genetics and drug metabolism in human cancer risk."Mutat. Res.247:267-281.
36.
Nebert, D.W. (1994). "Drug-metabolizing enzymes in ligand-modulated transcription."Biochem. Pharmacol.47:25-37.
37.
Nebert, D.W. and Gonzalez, F.J. (1987). "P450 genes and evolutionary genetics."Hosp. Practice22:63-74.
38.
Nebert, D.W., McKinnon, R.A., and Puga, A. (1996). "Human drug-metabolizing enzyme polymorphisms: Effects on risk of toxicity and cancer."DNA Cell. Biol.15:273-280.
39.
Nebert, D.W., Petersen, D.D., and Puga, A. (1991). "Human AH locus polymorphism and cancer: Inducibility of CYP1A1 and other genes by combustion products and dioxin."Pharmacogenetics1:68-78.
40.
Nebert, D.W., Puga, A., and Vasiliou, V. (1993). "Role of the Ah receptor and the dioxin-inducible [Ah] gene battery in toxicity, cancer and in signal transduction."Ann. NY Acad. Sci.685:624-640.
41.
Nebert, D.W. and Weber, W.W. (1990). "Pharmacogenetics." In: Principles of Drug Action. The Basis of Pharmacology, 3rd ed. (W.B. Pratt, P.W. Taylor, eds.) Churchill Livingstone Inc., New York, NY. pp. 469-531.
42.
Nei, M. and Saitou, N. (1986). "Genetic relationship of human populations and ethnic differences in reaction to drugs and food." In: Ethnic differences in reactions to drugs and xenobiotics. (W. Kalow, H.W. Goedde, D.P. Agarwal, eds.) Alan R. Liss, New York, NY. pp. 21-37.
43.
Passera, L., Roncin, E., Kaufmann, B., and Keller, L. (1996). "Increased soldier production in ant colonies exposed to intraspecific competition."Nature379:630-631.
44.
Pelkonen, O. and Nebert, D.W. (1982). "Metabolism of polycyclic hydrocarbons: etiologic role in carcinogenesis."Pharmacol. Rev.34:189-222.
45.
Pineau, T., Fernandez-Salguero, P., Lee, S.T.T., McPhail, T., Ward, J.M., and Gonzalez, F.J. (1995). "Neonatal lethality associated with respiratory distress in mice lacking cytochrome P450 CYP1A2."Proc. Natl. Acad. Sci. USA92:5134-5138.
46.
Plapp, F.W., JR (1981). "Toxicity of synthetic pyrethroids to laboratory and field populations of the tobacco budworm in central Texas."J. Econ. Entomol.74:201-209.
47.
Plapp, F.W. JR, and Wang, T.C. (1983). "Genetic origins of insecticide resistance." In: Pest Resistance to Pesticides. (G.P. Georghiou, T. Saito, eds.) Plenum Publishing Corp., New York, NY. pp. 47-70.
48.
Price-Evans, D.A. (1992). "N-acetyltransferase." In: Pharmacogenetics of drug metabolism. (W. Kalow, ed.) Pergamon Press, New York, NY. pp. 95-178.
49.
Rotter, J.I. and Diamond, J.M. (1987). "What maintains the frequencies of human genetic diseases?"Nature329:289-290.
50.
Safe, S. (1990). "Polychlorinated biphenyls (PCBs) and polybrominated biphenyls (PBBs): Biochemistry, toxicology and mechanisms of action."Toxicol.21:51-88.
51.
Swanson, H.I. and Bradfield, C.A. (1993). "The AH receptor: genetics, structure and function."Pharmacogenetics3:213-230.
52.
Tang, B.K., Zhou, Y., and Kalow, W. (1994). "Caffeine as a probe for CYP1A2 activity: Potential influence of renal factors on urinary phenotypic trait measurements."Pharmacogenetics4:117-124.
53.
Travisano, M., Mongold, J.A., Bennett, A.F., and Lenski, R.E. (1995). "Experimental tests of the roles of adaptation, chance, and history in evolution."Science267:87-90.
54.
Vasiliou, V., Weiner, H., Marselos, M., and Nebert, D.W. (1995). "Mammalian aldehyde dehydrogenase genes: classification based on evolution, structure and regulation."Eur. J. Drug Metab. Pharmacokin.20:53-64.
55.
Vatsis, K.P., Weber, W.W., Bell, D.A., Dupret, J.M., Price-Evans, D.A., Grant, D.M., et al. (1995). "Nomenclature for N-acetyltransferases."Pharmacogenetics5:1-17.
56.
Vogel, F. and Motulsky, A.G. (1986). Human GeneticsSpringer-Verlag . Berlin, Germany.
57.
Whitlock, J.P., JR (1991). "Genetic and molecular aspects of 2,3,7,8-tetrachlorodibenzo-p-dioxin action."Annu. Rev. Pharmacol. Toxicol.30:251-277.
58.
Yarbrough, J.D., Roush, R.T., Bonner, J.C., and Wise, D.A. (1986). "Monogenic inheritance of cyclodiene insecticide resistance in mosquitofish, Gambusia affinis."Experientia42:851-853.
59.
Yue, Q.Y., Svensson, J.O., Alm, C., Sjoqvist, F., and Säwe, J. (1989). "Interindividual and interethnic differences in the demethylation and glucuronidation of codeine."Br. J. Clin. Pharmacol.28:629-637.